Correlation Between FibroBiologics, Common and Atlantic American

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroBiologics, Common and Atlantic American at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroBiologics, Common and Atlantic American into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroBiologics, Common Stock and Atlantic American, you can compare the effects of market volatilities on FibroBiologics, Common and Atlantic American and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroBiologics, Common with a short position of Atlantic American. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroBiologics, Common and Atlantic American.

Diversification Opportunities for FibroBiologics, Common and Atlantic American

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between FibroBiologics, and Atlantic is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding FibroBiologics, Common Stock and Atlantic American in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atlantic American and FibroBiologics, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroBiologics, Common Stock are associated (or correlated) with Atlantic American. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atlantic American has no effect on the direction of FibroBiologics, Common i.e., FibroBiologics, Common and Atlantic American go up and down completely randomly.

Pair Corralation between FibroBiologics, Common and Atlantic American

Given the investment horizon of 90 days FibroBiologics, Common Stock is expected to under-perform the Atlantic American. In addition to that, FibroBiologics, Common is 2.05 times more volatile than Atlantic American. It trades about -0.12 of its total potential returns per unit of risk. Atlantic American is currently generating about -0.04 per unit of volatility. If you would invest  160.00  in Atlantic American on September 20, 2024 and sell it today you would lose (5.00) from holding Atlantic American or give up 3.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

FibroBiologics, Common Stock  vs.  Atlantic American

 Performance 
       Timeline  
FibroBiologics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FibroBiologics, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Atlantic American 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Atlantic American are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Atlantic American may actually be approaching a critical reversion point that can send shares even higher in January 2025.

FibroBiologics, Common and Atlantic American Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroBiologics, Common and Atlantic American

The main advantage of trading using opposite FibroBiologics, Common and Atlantic American positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroBiologics, Common position performs unexpectedly, Atlantic American can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atlantic American will offset losses from the drop in Atlantic American's long position.
The idea behind FibroBiologics, Common Stock and Atlantic American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments